This page collects WhisperX intelligence signals tagged #cell therapy. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
A small, early-stage study has demonstrated a potential path to the 'holy grail' of transplant medicine: immune tolerance. The research suggests that using cells from living liver donors could 'teach' a recipient's immune system to accept the foreign organ as its own, potentially eliminating the need for lifelong, risk...
Belgian pharmaceutical giant UCB is making a massive, high-stakes bet on the future of cell therapy, agreeing to acquire U.S.-based biotech Neurona Therapeutics for up to $1.15 billion. The deal, structured with an upfront payment and significant milestone-based earnouts, signals a decisive move by the established Euro...
Eli Lilly is set to acquire Kelonia Therapeutics for $3.2 billion, acquiring a company that came within days of insolvency on three separate occasions and operated on a shoestring budget of $60 million over five years. The acquisition, announced this week, represents a striking reversal of fortune for the privately hel...